Impact of biopsy perineural invasion on younger prostate cancer patients after radical prostatectomy

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA A Cancer J Clin. 2019;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Zhou CK, Check DP, Lortet-Tieulent J, et al. Prostate cancer incidence in 43 populations worldwide: an analysis of time trends overall and by age group. Int J Cancer. 2016;138(6):1388–1400.
   PubMed Web of Science ®Google Scholar
• Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev. 2005;26(6):833–876.
   PubMed Web of Science ®Google Scholar
• Heinlein CA, Chang C. Androgen receptor in prostate cancer. Endocr Rev. 2004;25(2):276–308.
   PubMed Web of Science ®Google Scholar
• Li J, German R, King J, et al. Recent trends in prostate cancer testing and incidence among men under age of 50. Cancer Epidemiol. 2012;36(2):122–127.
   PubMed Web of Science ®Google Scholar
• Wilson JM, Kemp IW, Stein GJ. Cancer of the prostate. Do younger men have a poorer survival rate? Br J Urol. 1984;56(4):391–396.
   PubMedGoogle Scholar
• Tjaden HB, Culp DA, Flocks RH. Clinical Adenocarcinoma of the Prostate in Patients under 50 Years of Age. J Urol. 1965;93:618–621.
   PubMed Web of Science ®Google Scholar
• Huben R, Natarajan N, Pontes E, et al. Carcinoma of prostate in men less than fifty years old. Data from American College of Surgeons' National Survey. Urology. 1982;20(6):585–588.
   PubMed Web of Science ®Google Scholar
• Bleyer A, Spreafico F, Barr R. Prostate cancer in young men: an emerging young adult and older adolescent challenge. Cancer. 2020;126(1):46–57.
   PubMed Web of Science ®Google Scholar
• Carter HB, Epstein JI, Partin AW. Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease. Urology. 1999;53(1):126–130.
   PubMed Web of Science ®Google Scholar
• Loeb S, Hernandez DJ, Mangold LA, et al. Progression after radical prostatectomy for men in their thirties compared to older men. BJU Int. 2008;101(12):1503–1506.
   PubMed Web of Science ®Google Scholar
• Khan MA, Han M, Partin AW, et al. Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003. Urology. 2003;62(1):86–91.
   PubMed Web of Science ®Google Scholar
• Parker PM, Rice KR, Sterbis JR, et al. Prostate cancer in men less than the age of 50: a comparison of race and outcomes. Urology. 2011;78(1):110–115.
   PubMed Web of Science ®Google Scholar
• Brassell SA, Rice KR, Parker PM, et al. Prostate cancer in men 70 years old or older, indolent or aggressive: clinicopathological analysis and outcomes. J Urol. 2011;185(1):132–137.
   PubMed Web of Science ®Google Scholar
• Freedland SJ, Presti JC Jr., Kane CJ, et al. Do younger men have better biochemical outcomes after radical prostatectomy? Urology. 2004;63(3):518–522.
   PubMed Web of Science ®Google Scholar
• Thorstenson A, Garmo H, Adolfsson J, et al. Cancer specific mortality in men diagnosed with prostate cancer before age 50 years: a nationwide population based study. J Urol. 2017;197(1):61–66.
   PubMed Web of Science ®Google Scholar
• Mahran A, Turk A, Buzzy C, et al. Younger men with prostate cancer have lower risk of upgrading while on active surveillance: a meta-analysis and systematic review of the literature. Urology. 2018;121:11–18.
   PubMed Web of Science ®Google Scholar
• Mahal BA, Butler S, Franco I, et al. Use of active surveillance or watchful waiting for low-risk prostate cancer and management trends across risk groups in the United States, 2010–2015. JAMA. 2019;321(7):704–706.
   PubMed Web of Science ®Google Scholar
• Thompson I, Thrasher JB, Aus G, et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol. 2007;177(6):2106–2131.
   PubMed Web of Science ®Google Scholar
• Shariat SF, Karakiewicz PI, Suardi N, et al. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature. Clin Cancer Res. 2008;14(14):4400–4407.
   PubMed Web of Science ®Google Scholar
• Wu S, Lin X, Lin SX, et al. Impact of biopsy perineural invasion on the outcomes of patients who underwent radical prostatectomy: a systematic review and meta-analysis. Scand J Urol. 2019;10:1–8.
   Google Scholar
• Hussein S, Satturwar S, Van der Kwast T. Young-age prostate cancer. J Clin Pathol. 2015;68(7):511–515.
   PubMed Web of Science ®Google Scholar
• Salinas CA, Tsodikov A, Ishak-Howard M, et al. Prostate cancer in young men: an important clinical entity. Nat Rev Urol. 2014;11(6):317–323.
   PubMed Web of Science ®Google Scholar
• Fang AM, Glaser ZA, Rais-Bahrami S. Increasing the use of active surveillance for prostate cancer in younger men. Cancer. 2019;125(19):3292–3295.
   PubMed Web of Science ®Google Scholar
• Leapman MS, Cowan JE, Nguyen HG, et al. Active surveillance in younger men with prostate cancer. J Cin Oncol. 2017;35(17):1898–1904. 10
   PubMed Web of Science ®Google Scholar
• Samadi DB, Sebrow D, Hobbs AR, et al. Clinicopathological, functional, and immediate oncologic outcome assessment in men aged ≤ 50 years with prostate cancer after robotic prostatectomy. Urol Oncol. 2017;35(1):30e17–30.e24.
   Web of Science ®Google Scholar
• Lesko SM, Rosenberg L, Shapiro S. Family history and prostate cancer risk. Am J Epidemiol. 1996;144(11):1041–1047.
   PubMed Web of Science ®Google Scholar
• Hernandez DJ, Nielsen ME, Han M, et al. Contemporary evaluation of the D'amico risk classification of prostate cancer. Urology. 2007;70(5):931–935.
   PubMed Web of Science ®Google Scholar
• D'Amico AV, Tempany CM, Schultz D, et al. Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate. Urology. 2003;62(6):1063–1067.
   PubMed Web of Science ®Google Scholar
• Harnden P, Shelley MD, Naylor B, et al. Does the extent of carcinoma in prostatic biopsies predict prostate-specific antigen recurrence? A systematic review. Eur Urol. 2008;54(4):728–739.
   PubMed Web of Science ®Google Scholar
• Bismar TA, Lewis JS Jr., Vollmer RT, et al. Multiple measures of carcinoma extent versus perineural invasion in prostate needle biopsy tissue in prediction of pathologic stage in a screening population. Am J Surg Pathol. 2003;27(4):432–440.
   PubMed Web of Science ®Google Scholar
• Cozzi G, Rocco BM, Grasso A, et al. Perineural invasion as a predictor of extraprostatic extension of prostate cancer: a systematic review and meta-analysis. Scand J Urol. 2013;47(6):443–448.
   PubMed Web of Science ®Google Scholar
• Kryvenko ON, Diaz M, Meier FA, et al. Findings in 12-core transrectal ultrasound-guided prostate needle biopsy that predict more advanced cancer at prostatectomy: analysis of 388 biopsy-prostatectomy pairs. Am J Clin Pathol. 2012;137(5):739–746.
   PubMed Web of Science ®Google Scholar
• Stone NN, Stock RG, Parikh D, et al. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate. J Urol. 1998;160(5):1722–1726.
   PubMed Web of Science ®Google Scholar
• Swyer GI. Post-natal growth changes in the human prostate. J Anat. 1944;78(Pt 4):130–145.
   PubMedGoogle Scholar
• Chapple CR, Crowe R, Gilpin SA, et al. The innervation of the human prostate gland-the changes associated with benign enlargement. J Urol. 1991;146(6):1637–1644.
   PubMed Web of Science ®Google Scholar
• Villers A, McNeal JE, Redwine EA, et al. The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J Urol. 1989;142(3):763–768.
   PubMed Web of Science ®Google Scholar
• Ayala GE, Dai H, Ittmann M, et al. Growth and survival mechanisms associated with perineural invasion in prostate cancer. Cancer Res. 2004;64(17):6082–6090.
   PubMed Web of Science ®Google Scholar
• Ayala GE, Dai H, Tahir SA, et al. Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma. Cancer Res. 2006;66(10):5159–5164.
   PubMed Web of Science ®Google Scholar
• Fromont G, Godet J, Pires C, et al. Biological significance of perineural invasion (PNI) in prostate cancer. Prostate. 2012;72(5):542–548.
   PubMed Web of Science ®Google Scholar
• Bastian PJ, Mangold LA, Epstein JI, et al. Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysis. Cancer. 2004;101(9):2001–2005.
   PubMed Web of Science ®Google Scholar
• Harryman WL, Warfel NA, Nagle RB, et al. The tumor microenvironments of lethal prostate cancer. Adv Exp Med Biol. 2019;1210:149–170.
   PubMed Web of Science ®Google Scholar